Peter Thiel-backed psychedelic drug maker aims to raise $100M in IPO ...Middle East

Psychedelic drugmaker ATAI Life Science, which backed by billionaire investor Peter Thiel, said it is planning to raise $100 million in an initial public offering. The Berlin-based company — which tests drugs like ketamine, DMT and psilocybin, the active ingredient in “magic mushrooms,” to treat depression — raised an aggregate of $362.3 million from private...

Hence then, the article about peter thiel backed psychedelic drug maker aims to raise 100m in ipo was published today ( Wednesday 21/04/2021 - 06:32 PM ) and is available on New York Post ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Peter Thiel-backed psychedelic drug maker aims to raise $100M in IPO )

Also on site :

• Sony to stop making physical discs for PlayStation starting in 2028